Flow cytometric significance of cellular alkaline phosphatase activity in acute myeloid leukemia

In this prospective hospital-based cohort study that included 43 newly diagnosed patients with acute myeloid leukemia, flow cytometric cellular alkaline phosphatase (ALP) activity within primitive leukemic cells allowed us to identify two groups of patients at diagnosis according to the numbers of l...

Descripción completa

Detalles Bibliográficos
Autores: G. Rico, Laura|||0000-0001-9867-4393, Junca, Jordi|||0000-0003-0142-772X, Ward, Michael D., Bradford, Jolene A., Petriz, Jordi|||0000-0003-1085-0511
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:227886
Acceso en línea:https://ddd.uab.cat/record/227886
https://dx.doi.org/urn:doi:10.18632/oncotarget.27356
Access Level:acceso abierto
Palabra clave:Alkaline phosphatase
Acute myeloid leukemia
Stem cells
Leukemic stem cells
CD34
Descripción
Sumario:In this prospective hospital-based cohort study that included 43 newly diagnosed patients with acute myeloid leukemia, flow cytometric cellular alkaline phosphatase (ALP) activity within primitive leukemic cells allowed us to identify two groups of patients at diagnosis according to the numbers of leukemic blasts expressing ≥ 12% of ALP+ cells (27 patients, Group A) and less than 12% of ALP+ cells (16 patients, Group B). Differences in outcome for complete response, relapse or treatment resistance, and exitus were statistically analyzed and were significant, when comparing the two groups. The overall survival (OS) and event-free survival (EFS) differences between Group A and B were statistically significant. The survival of Group A patients was significantly shorter than those for Group B. No significant relationship was detected in outcome when comparing ELN prognostic-risk group based on cytogenetic and molecular profile (patients in the favorable, intermediate, and adverse risk groups). Flow cytometric cellular ALP activity at diagnosis may be used to estimate relapses and disease persistence more accurately. The limitations of our study include the small number of patients enrolled and a short follow-up, due to its prospective nature.